SALT LAKE CITY and SEATTLE, Nov. 6, 2019 /PRNewswire/ -- Qualtrics, the leader in customer experience and creator of the experience management (XM) category, today announced the launch of the XM Healthcare Advisory Board where members will collaborate on XM solutions to improve the experiences of patients, providers, and payers. The

TAOYUAN, Taiwan, Nov. 6, 2019 /PRNewswire/ -- On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.

DUBLIN, Nov. 6, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care ProductsTM", today announced financial results for the third quarter ended September 28, 2019.

CHICAGO, Nov. 6, 2019 /PRNewswire/ -- A new report by Moody's Analytics revealed the serious impact millennials' health could have on the U.S. economy. Compared to when Generation X was the same age, millennials are projected to experience slower economic growth and pay more in health care costs over the next decade, which could have a crippling effect on the economy, ac

MINNEAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Basecamp Fitness, a fast-paced and efficient wellness concept, today announced a new

LAS VEGAS, Nov. 6, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces a delay in the sale of GB Sciences Louisiana LLC. 

PROVIDENCE, R.I., Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" in

FRANKFURT, Germany, Nov. 6, 2019 /PRNewswire/ -- (Booths #F62 & #F10 -Hall 11.1)  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in inno

BOULDER, Colo., Nov. 6, 2019 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2020 second quarter that ended September 30, 2019

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective authorities. The preclinical drug candidates are currently undergoing preparatory steps to meet the regulatory requirements for obtaining permission t